Retropupillary Iiris Claw Lens Implantation In Pediatric Patients Of Marfan’S Syndrome
Published 2024 - 42nd Congress of the ESCRS
Reference: FP10.11 | Type: Free paper | DOI: 10.82333/39wn-ty37
Authors: Drushya Reddy* 1 , JK Reddy 2 , vandhana sundaram 2 , Mithun Thulasidas 3
1cataract,Sankara Academy Of Vision,coimbatore,India, 2cornea,cataract and refractive surgery,Sankara Academy Of Vision,coimbatore,India, 3cataract and glaucoma,Sankara Academy Of Vision,coimbatore,India
Purpose
To assess the visual outcome, corneal endothelial cell loss and complication rates after retropupillary iris claw lens implantation in pediatric patients with ectopia lentis secondary to Marfan's syndrome.
Setting
This Retrospective study comprised of 34 eyes of 24 children with subluxation of natural lens in Marfan’s syndrome with inadequate capsular support who underwent lensectomy followed by primary/secondary retropupillary iris claw lens implantation between 2011 and 2023 at the cornea department of sankara eye hospital,Coimbatore.
Methods
In this retrospective study, 34 eyes of 24 children with subluxation of the natural lens due to Marfan's syndrome with inadequate capsular support underwent lensectomy with primary or secondary retropupillary iris claw lens implantation from 2011 to 2023 at our institution. Preoperative and postoperative uncorrected visual acuity (UCVA), best-corrected visual acuity (BSCVA), intraocular pressure (IOP), endothelial cell count (ECC), and the occurrence of other complications were measured.
Results
The average patient age - 8.5 years(age range: 4-17 years) and the mean follow-up duration - 25.38 months (range: 2 to 117 months). LogMAR BSCVA significantly improved from 0.85±0.30 preoperatively to 0.38±0.20 postoperatively during the final follow-up visit (P < 0.0001). Postoperative intraocular pressure averaged 15.5 mmHg (range: 9–26 mmHg). The mean endothelial cell density decreased from 2907.35±387.07 cells/mm2 preoperatively to 2612.02±435.90 cells/mm2 post-surgery, indicating an average endothelial cell loss of 10.16% by the study's conclusion.
Conclusions
Retropupillary iris-claw implantation is an effective and safe procedure for pediatric patients with ectopia lentis secondary to Marfan's syndrome offering improved visual outcomes with minimal postoperative endothelial cell loss.